Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Trial of a WT1 Analog Peptide Vaccine in Patients With Multiple Myeloma Following Autologous Stem Cell Transplantation

NCT01827137 is registered in ClinicalTrials.gov with Sellas Life Sciences Group as lead sponsor.

NCT NCT01827137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01827137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Trial of a WT1 Analog Peptide Vaccine in Patients With Multiple Myeloma Following Autologous Stem Cell Transplantation
Lead sponsor
Sellas Life Sciences Group
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2013
Completion date
November 6, 2017
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma